OSTN and Cachexia: Even more importantly, in the plasma of C26-bearing mice at times when their body weights did not differ from that of PBS-injected ones and muscles were not yet wasted, the circulating levels of musclin had already decreased (Figure 3p), supporting it as a possible biomarker predicting cancer cachexia.